These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D. Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463 [Abstract] [Full Text] [Related]
4. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial. Kahrilas PJ, Fennerty MB, Joelsson B. Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737 [Abstract] [Full Text] [Related]
5. A comparison of five maintenance therapies for reflux esophagitis. Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A. N Engl J Med; 1995 Oct 26; 333(17):1106-10. PubMed ID: 7565948 [Abstract] [Full Text] [Related]
9. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies. Howden CW, Henning JM, Huang B, Lukasik N, Freston JW. Am J Gastroenterol; 2001 Jun 26; 96(6):1704-10. PubMed ID: 11419818 [Abstract] [Full Text] [Related]
11. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group. Farley A, Wruble LD, Humphries TJ. Am J Gastroenterol; 2000 Aug 26; 95(8):1894-9. PubMed ID: 10950032 [Abstract] [Full Text] [Related]